The Medical Advisor

According to the 2022 South Korean study by Lee et al: "it is necessary to discover novel chemotherapeutic agents and develop effective therapeutic strategies in pancreatic cancer." "This is the first study to evaluate the anticancer effects of the combination of Ivermectin and gemcitabine in pancreatic cancer." "We found that the ivermectin–gemcitabine combination treatment suppressed pancreatic cancer more effectively than gemcitabine alone treatment."  "In vivo experiments confirmed that the ivermectin–gemcitabine group had significantly suppressed tumor growth compared to the gemcitabine alone group". "These results indicate that ivermectin exerts synergistic effects with gemcitabine, preventing pancreatic cancer progression, and could be a potential antitumor drug for the treatment of pancreatic cancer." Related:   Stage 4 Pancreatic Cancer – Fenbendazole Protocol Shrinking Tumors and Dropping Cancer Markers Hydroxychloroquine and...

Adding high-dose vitamin C to a cancer treatment regimen may double survival time, according to a clinical trial that tested this in pancreatic cancer patients. Typically diagnosed in its advanced stages, pancreatic cancer has a poor prognosis and leaves patients with limited treatment options, with most surviving only eight months with standard chemotherapy. “When we started the trial, we thought it would be a success if we got to 12 months survival, but we doubled overall survival to 16 months,” senior study author Dr. Joe Cullen, professor of surgery and radiation oncology at the University of Iowa, said in a press statement . “The results were so strong ... that we were able to stop the trial early.” Published in the November issue of Redox Biology, the study suggests that high-dose vitamin C may not only help slow or even kill cancer cells but also reduce the physical suffering of those undergoing chemotherapy. Better Tolerance and Fewer Side Effects The phase 2 trial showed that...

I’m a smoker. I’ve smoked a pack a day for almost 20 years. Knowing all that I do about health and medicine, you’d have to think I’m either crazy or suicidal, right? Why would I carry on smoking veritable cancer sticks, day in day out, knowing all we do about the risks? I do not fear cancer. (Nor the other pathologies it can cause - but that’s a discussion for another day.) If I die of cancer one of these days, please feel free to put this right alongside my obituary and laugh at me, because it isn’t going to happen. One of the most insidious methodological switches that has been applied to modern medicine is a severe overreliance on statistical interpretations of trial data, to the exclusion of any significant consideration of proteomic interactions or mechanisms, which are instead relegated to curiosities of interest only to the scientists investigating them, with very little transference to the discovery and announcement of useful therapeutics. This switch has enabled the powers th...